Meaningful negative changes in Viavi Solutions Inc (NASDAQ: VIAV) fundamentals have recently occurred: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, and the consensus estimate for June, 2024 decreased significantly. Viavi Solutions Inc […]
Recent exceptional negative changes in investment behavior have affected Trio-Tech International (NYSEAMERICAN: TRT): the stock’s recent price decline challenged its longer term uptrend, and the stock fell on very heavy volume. Meaningful negative changes in […]
Kingstone Cos Inc (NASDAQ: KINS) stock enjoyed a major increase of 14.7% on 5/14/24. The shares closed at $4.60. Moreover, this advance was accompanied by exceptionally high trading volume at 302% of normal. The stock […]
On 5/14/24, Intellinetics Inc (NYSEAMERICAN: INLX) stock enjoyed a major increase of 13.1%, closing at $8.25. NORMAL trading volume accompanied the advance. Relative to the market the stock has been exceptionally strong over the last […]
Harsco Corp (NYSE: HSC) has benefited from exceptional positive changes in investment behavior: its longer term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside volume developed, and […]
Fennec Pharmaceuticals Inc (NASDAQ: FENC) has reported E.P.S. of $0.47 for its first fiscal quarter (ending March 31) versus $-0.23 for the same period a year ago. This result exceeded the consensus estimate of $0.44 […]
On 5/14/24, Delcath Systems Inc (NASDAQ: DCTH) stock enjoyed a major increase of 30.9%, closing at $7.07. However, trading volume in this advance was exceptionally low at -2292% of normal. The stock has been strong […]
Agilysys Inc (NASDAQ: AGYS) stock closed at $92.16 on 5/14/24 after a major increase of 14.9%. Moreover, trading volume in this advance was exceptionally high at 297% of normal. The stock has risen 15.9% during […]
Radcom Ltd (NASDAQ: RDCM) stock closed at $10.54 on 5/14/24 after a major increase of 12.1%. Moreover, trading volume in this advance was above average at 120% of normal. The stock has risen 8.8% during […]
OptimizeRX Corp (NASDAQ: OPRX) has reported a loss for its first fiscal quarter (ending March 31) of $-0.38 versus a loss $-0.37 for the same period a year ago. For the latest four quarters through […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research